India-EU trade deal will boost access to medicines, create more opportunities: Experts

Youngsuk ‘YS’ Chi, Chairman of Elsevier, highlighted the benefits of the India-EU trade deal collaboration, stating, “I think the businesses will benefit by making sure that we collaborate on every front possible to move as much talent, as much goods, and even intellectual property to benefit both countries and the rest of the world.”

The agreement will eliminate tariffs on 90% of European medical and surgical equipment and reduce tariffs on pharmaceuticals, potentially doubling EU exports to India by 2032.

Read more>